Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Health literacy association with health behaviors and health care utilization in multiple sclerosis: a cross-sectional study.
Severe Cognitive Impairment Associated With Intrathecal Antibodies to the NR1 Subunit of the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis.
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.
Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis.
Multitasking in Multiple Sclerosis: Can it Inform Vocational Functioning?
Role Preferences of People with Multiple Sclerosis: Image-Revised, Computerized Self-Administered Version of the Control Preference Scale.
Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study.
Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases.
Internal jugular vein blood flow in multiple sclerosis patients and matched controls.
Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP).
Rituximab for tumefactive demyelination refractory to corticosteroids and plasma exchange.
Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?
The Y chromosome as a regulatory element shaping immune cell transcriptomes and susceptibility to autoimmune disease.
Comment on "Fingolimod effects on left ventricular function in multiple sclerosis" Mult Scler 2015.
[Support from a non-profit organisation to improve Multiple sclerosis patients' quality of life].
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?
The challenges of measuring disability accumulation in relapsing-remitting multiple sclerosis: evidence from interferon beta treatments.
Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS). (REFINE)
The Severity of Bowel Dysfunction in Patients with Neurogenic Bladder.
Efficacy of Tryptophan Immunoadsorption Plasmapheresis for Neuromyelitis Optica in Two Cases.
Assessing disability weights based on the responses of 30,660 people from four European countries.
Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination.
Guideline for the diagnosis and management of multiple sclerosis in children.
Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course.

Pages